Bo Ryeong Lee

Combination of PD-L1 and PVR determines sensitivity to PD-1 blockade

Bo Ryeong Lee, Sehyun Chae, Jihyun Moon et al. · JCI Insight · 2020 · 44 citations · Full text

Life Sciences, Immunology, Oncology +17

Peptidylarginine deiminase inhibition impairs Toll-like receptor agonist-induced functional maturation of dendritic cells, resulting in the loss of T cell–proliferative capacity: a partial mechanism with therapeutic potential in inflammatory settings

Byungki Jang, Ho Won Kim, Jong-Seok Kim et al. · Journal of Leukocyte Biology · 2014 · 34 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity

Woo Sik Kim, Hongmin Kim, Kee Woong Kwon et al. · Oncotarget · 2016 · 31 citations · Full text

Life Sciences, Immunology, Oncology +17

Combination of TLR1/2 and TLR3 ligands enhances CD4+ T cell longevity and antibody responses by modulating type I IFN production

Bo Ryeong Lee, Soo Kyung Jeong, Byung Cheol Ahn et al. · Scientific Reports · 2016 · 25 citations · Full text

Life Sciences, Immunology, Innate Immunity +16

A small molecule inhibitor for ATPase activity of Hsp70 and Hsc70 enhances the immune response to protein antigens

Kyung-Hwa Baek, Haiying Zhang, Bo Ryeong Lee et al. · Scientific Reports · 2015 · 18 citations · Full text

Life Sciences, Immunology, Pharmacology +17